Clínica Baviera SA (CBAV)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Mar 14, 2025

$38.09

P/E Ratio

15.91

Market Cap

$621.02M

Mar 27, 2024May 3, 2024Jun 5, 2024Jul 5, 2024Aug 7, 2024Sep 9, 2024Oct 11, 2024Nov 15, 2024Dec 20, 2024Jan 29, 2025Mar 14, 2025$0.00$10.00$20.00
  • HOME
Description
Add to research
View more

Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. It specializes in the treatment of glaucoma, cataract, vitreous and retinal detachment, and strabismus or squinting. The company was founded by Eduardo Baviera Sabater, Julio Baviera Sabater, Luis Miguel Raga, and Fernando Llovet Osuna on February 5, 1992 and is headquartered in Madrid, Spain.

Metrics
Add to research
View more

Overview

  • HQMadrid, MA
  • SectorHealth Services
  • IndustryHospital/Nursing Management
  • TickerCBAV
  • Price$38.091517-1.35%

Trading Information

  • Market cap$621.02M
  • Float8.50%
  • Average Daily Volume (1m)3,881
  • Average Daily Volume (3m)2,617
  • EPS$2.21

Company

  • Revenue$224.92M
  • Rev growth (1yr)N/A
  • Net income$4.05M
  • Gross margin10.11%
  • EBITDA margin19.58%
  • EBITDA$11.25M
  • EV$609.27M
  • EV/Revenue2.71
  • P/E15.91
  • P/S2.54
  • P/B6.83
  • Debt/Equity73.41
Documents
Add to research
View more